Novo partners with Anthropic to speed up drug development with Claude
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
Sept 16 : Novo Nordisk has partnered with Anthropic to use the AI giant’s Claude models to speed up discovery and development of new medicines, the companies said on Wednesday.
Here are more details:
• The Danish drugmaker will initially test Anthropic models and Claude Science in its research and development workflows, and address scientific problems where their joint capabilities can have the greatest impact, they said.
• “But beyond this, AI tools can also offer completely new scientific opportunities and aid reasoning and understanding of human biology and drug mechanics,” Novo CEO Mike Doustdar said.
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
• Drugmakers are increasingly turning to artificial intelligence to accelerate R&D and improve efficiency across their pipelines.
• The Wegovy maker will also use Anthropic’s frontier models to strengthen AI-driven software development.
• “By giving leading researchers access to safe, capable, and trusted frontier models, we can shorten research timelines, improve outcomes, and discover medicines and treatments that significantly improve human life,” said Dario Amodei, CEO of Anthropic.
• Meanwhile, AI industry leaders are split over how fast companies should develop the increasingly powerful technology.
• Novo already uses Claude to automate trial report generation, and trim timelines for patient documentation creation from months to minutes.
Source: Reuters
Sign up for our newsletters
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
